Lipedema World Alliance Board Members Dr Gabriele Faerber (Germany), Dr Thomas Wright (USA), Dr José Luis Simarro (Spain) and Dr Manuel Cornely (Germany) will discuss their experiences of treating patients with GLP1-RA medications such as Liraglutide/Saxenda and Semaglutide/Wegovy.
Are there differences in the experiences and treatment of patients with lipedema vs patients with obesity? What considerations apply to the use of GLP 1 Receptor Agonists in lipedema patients? How do patients with lipedema react to these medications? How do these new medicines compare with other weight loss treatments?
LWA Board Members discuss their clinical experiences and recommendations/acknowledgements of the limits of current lipedema-specific research on these medications.
Please go to our YouTube Channel here
